一夜疯狂的双黄连：有中药企业大年初二就开始加班生产。
Crazy night Shuanghuanglian: Chinese medicine enterprises began to work overtime on the second day of the year.
新京报                      。
Beijing News.
新京报。
Beijing News.
关键时刻还看新京报！这里有最生猛的调查报道，这里有朋友圈最重磅的深度文章。
Key moment to see the Beijing News! Here are the most violent investigation reports, here are the most weighty in-depth articles in the circle of friends.
只提供有价值的新闻，只负责挖掘真相！慧眼看中国，我们就是你的4D眼镜。
Only provide valuable news, only responsible for digging the truth! Look at China, we are your 4D glasses.
。
.
最近3天左右，哈中药四厂就接到了一些公司的双黄连口服液订单，“它是传统组方，针对清热解毒，其中的金银花也有抗炎的作用”。
In the past three days or so, four plants have received some companies Shuanghuanglian oral liquid order, "it is a traditional group of antipyretic detoxification, among which honeysuckle also has anti-inflammatory effect."
对于抑制新型冠状病毒的效用，黄玉珠认为“具体还需要实验的数据”。
For the suppression of the effectiveness of the new coronavirus, Huang Yuzhu believes that "specific experimental data is needed."
全文3762字，阅读约需7.5分钟“十来箱（双黄连口服液）半个小时就没了！”2月1日，河南某市三甲医院药房工作人员苏兰（化名）告诉新京报记者，因双黄连紧缺，医院已经只针对发热门诊开双黄连口服液。
"On February 1, Sulan (not his real name), a pharmacy worker at Sanjia Hospital in Henan, told the Beijing News that the hospital had only been dispensing Shuanghuanglian oral liquid for the fever clinic because of the shortage of Shuang Huanglian.
与此同时，远在东莞市的一家双黄连口服液生产厂商，已经接到东莞市政府加大生产双黄连口服液的通知，“今日开始复工生产”。
Meanwhile, Shuang Huanglian, an oral liquid manufacturer in Dongguan, has been informed by the Dongguan government to increase its production of Shuanghuanglian oral liquid.
双黄连口服液一夜之间变得紧俏，与1月31日晚间中科院上海药物所与武汉病毒所联合发布的一项研究有关：“研究初步发现，中成药双黄连口服液可抑制新型冠状病毒。
Shuanghuanglian oral liquid overnight became tight, and the Chinese Academy of Sciences Shanghai Medicine Institute and Wuhan virus released a joint study on the evening of January 31: "Preliminary findings suggest that the Chinese patent medicine Shuanghuanglian oral liquid can inhibit the new coronavirus.
”随后，各大电商平台的双黄连口服液等产品被一抢而空。
Subsequently, the major electric business platform Shuanghuanglian oral liquid and other products were snatched up.
湖北省人民政府网凌晨转发的消息称，现代医学研究认为，双黄连口服液具有广谱抗病毒、抑菌、提高机体免疫功能的作用，是目前有效的广谱抗病毒药物之一。
Modern medical research shows that Shuanghuanglian oral liquid has the functions of broad-spectrum anti-virus, bacteriostatic and immune function enhancement, and is one of the effective broad-spectrum antiviral drugs, Hubei Provincial People's Government Web in the wee hours.
“目前，双黄连口服液已在上海公共卫生临床中心、华中科技大学附属同济医院开展临床研究。
"At present, Shuanghuanglian oral liquid has been carried out clinical research in Tongji Hospital affiliated with Shanghai Public Health Clinical Center and Huazhong University of Science and Technology.
”不过，双黄连口服液真的能抑制新型冠状病毒吗？有专家及医学人士提出了质疑：没有足够的公开数据能证明它在人体中“可抑制新型冠状病毒”。
But does Shuang Huanglian oral liquid really suppress the coronavirus? Experts and medical experts have questioned whether there is enough open data to prove that it "inhibits the new coronavirus" in humans.
━━━━━双黄连口服液“抑制冠状病毒”？有医院限量开药2月1日一大早，在河南某市三甲医院药房工作的苏兰（化名）接到库房主任电话，要留一箱双黄连口服液，随后又收到晚班值班同事的消息，“赶紧报双黄连计划，排队买”。
--2008.09.19 An early morning on Feb. 1, Sulan (not his real name) working at a Sanjia hospital pharmacy in Henan received a telephone call from the director of the warehouse asking him to leave a case of Shuanghuanglian oral liquid.
值班的同事告诉苏兰，有患者昨晚来买双黄连，但已经没有货，让对方早上再来买。
The colleague on duty told Sulan that a patient came last night to buy Shuanghuanglian, but there was no stock, let the other side buy again in the morning.
“十来箱半个小时就没了”，苏兰对记者说道。
"Ten cases are gone in half an hour," Sulan told reporters.
双黄连一售而空，苏兰赶紧联系医院采购，“医药公司说凌晨两点就有人来要货了，现在只能开始分配，各个医院都分配一点，不能说谁先抢就是谁的”，“最后药学部通知只能发热门诊开药（双黄连口服液），最多7天的量”。
"The pharmaceutical company said there was someone to pick it up at 2: 00 in the morning, and now it had to start distributing it. Each hospital was allocated a bit, so it can't be said that anyone could take it first.
苏兰建议市民，不要随意来医院排队购买双黄连口服液，“医院出现疑似病例，来医院并不安全”。
Suran advised the public, do not line up at the hospital to buy Shuang Huanglian oral liquid, "hospital suspected cases, hospital is not safe."
1月31日晚，中国科学院上海药物所与武汉病毒所联合发布，“研究初步发现，中成药双黄连口服液可抑制新型冠状病毒。
On the evening of January 31, the Shanghai Medicine Institute of the Chinese Academy of Sciences and Wuhan Virus Institute jointly released, "Preliminary findings suggest that the Chinese patent medicine Shuanghuanglian oral liquid can inhibit the new coronavirus.
”随后，新京报记者查看淘宝、京东、苏宁等电商平台发现，大部分商品显示无货或下架。
Subsequently, the Beijing News reporter looked at Taobao, Jingdong, Suning and other electric business platforms and found that most of the goods showed no goods or shelves.
但是，双黄连口服液真的能抑制新型冠状病毒吗？一些医学专家对此提出了不同的看法。
But does Shuangwanglian oral liquid really inhibit the new coronavirus? Some medical experts have come up with a different view.
2月1日丁香医生发文称，想要想要证明一种药物真实有效需要进行动物实验、一期临床试验、二期临床试验、三期临床试验。
Dr. Lilac wrote on Feb. 1 that to prove a drug is true and effective requires an animal trial, a first-phase clinical trial, a second-phase clinical trial, and a third-phase clinical trial.
而上海药物所与武汉病毒所的表态为“目前，双黄连口服液已在上海公共卫生临床中心、华中科技大学附属同济医院开展临床研究。
"At present, Shuanghuanglian oral liquid has been carried out clinical research in Tongji Hospital, affiliated with Huazhong University of Science and Technology.
”才开始做临床试验，没有足够的公开数据能证明它在人体中“可抑制新型冠状病毒”。
Clinical trials have only begun, and there is not enough public data to prove that it "inhibits the new coronavirus" in humans.
人民日报2月1日早间也发布微博提示，“抑制并不等于预防和治疗”。
People's Daily February 1 early also issued a micro-blog reminder that "suppression is not equal to prevention and treatment."
按照世界卫生组织的说法，“到目前为止，还没有用于预防和治疗新型冠状病毒的药物”。
"So far, there is no drug for the prevention and treatment of this coronavirus," according to the World Health Organization.
Play▲上海市民深夜抢购双黄连口服液 药店工作人员连呼“卖完了”。
Shanghai residents snapped up late-night Shuangwanglian oral liquid pharmacy staff shouted "sold out."
新京报我们视频出品（ID：wevideo）━━━━━需求狂热之下，有工厂应政府要求扩大生产在“中成药双黄连口服液可抑制新型冠状病毒”的消息发布后，各大双黄连口服液的制药厂状况如何？“订单非常多”，“很多公司都是有多少要多少”，哈中药四厂的总工程师黄玉珠2月1日对新京报记者表示。
In a frenzy of demand, some factories expanded production at the government's behest What about the pharmaceutical factories of Shuanghuanglian Oral Liquid to suppress the new coronavirus? Order is very large and many companies need as much as they need, Huang Yuzhu, chief engineer of the company, told the Beijing News on Feb. 1.
黄玉珠称，哈中药四厂在初二就开始提前生产双黄连口服液，目前工厂的年产能达到7000万至8000万支，该口服液的生产周期比较长，“从原料提取到出厂可能要半个月”。
According to Topaz, the plant began to produce Shuanghuanglian oral liquid ahead of schedule on the second day of the year. The plant currently has an annual production capacity of 70-80 million units.
最近3天左右，哈中药四厂就接到了一些公司的双黄连口服液订单，“它是传统组方，针对清热解毒，其中的金银花也有抗炎的作用”。
In the past three days or so, four plants have received some companies Shuanghuanglian oral liquid order, "it is a traditional group of antipyretic detoxification, among which honeysuckle also has anti-inflammatory effect."
对于抑制新型冠状病毒的效用，黄玉珠认为“具体还需要实验的数据”，“在目前疫情情况下，起码对清热和抗炎是有作用的”。
To suppress the utility of the new coronavirus, Huang Yuzhu believes that "experimental data are needed," and that "in the current epidemic situation, at least for heat removal and anti-inflammatory effects."
“目前政府可能还会集中采购，哈尔滨新区政府和省药监最近也一直关注我们的产能，他们要了解一下情况，对后续整体药品调配可能会有一个考虑”，黄玉珠说道。
"The government is likely to focus on procurement right now, and the government and provincial drug inspectors in Harbin have been looking at our production capacity recently. They want to know what the situation is, and there may be a consideration for further overall drug deployment," he said.
Play▲中药企业回应双黄连抑制新冠病毒：大年初二就开始加班生产。
Chinese medicine enterprises respond to Shuanghuanglian inhibition of the new crown virus: New Year's Day began overtime production.
新京报我们视频出品（ID：wevideo）2月1日，新京报记者致电富森药业，市场部工作人员回应称，公司原本就已经在加大生产，“我们已经跟政府沟通好了，至于是如何沟通的我不太清楚”。
The Beijing News called Fujimori Pharmaceutical on Feb. 1, and marketing staff responded that the company was already stepping up production. "We have communicated with the government, and I'm not sure how."
另一位工作人员对记者表示，公司大概是从初二初三的时候就开始加班加点生产，在全负荷状况下，前两年的双黄连口服液的年产能就达到了10亿支。
Another staff member told reporters that the company has been working overtime since about the third day of junior high school, and at full capacity, the previous two years of Shuanghuanglian oral liquid production capacity reached 1 billion.
2月1日，新京报记者联系到黑龙江瑞格制药有限公司，该公司工作人员对记者表示，目前疫情较为严重，公司唯一能做的就是正常生产，也没有出现加班加点生产的情况，“我们现在有些市场已经断货了，着急发货，但是产量是有限的，不是想扩大就扩大，而且没有经过相关的批准也不能随便私自增加产量”，“如果全年生产，双黄连口服液的产能在1亿—1.5亿支”，与上述两家企业不同的是，位于广东的东莞市亚洲制药有限公司工作人员告诉记者，公司最高年产双黄连口服液在5亿支左右，主要销往广东本地，目前已经接到了东莞市政府加大生产双黄连口服液的通知。
Unlike Heilongjiang Rigg Pharmaceuticals, a company whose staff told reporters that the company's annual production capacity is about 500 million, the company's highest annual production capacity is about 500 million, not only to expand without relevant approval, but also to increase production without approval.
“今天开始正常生产，昨天上海药物所的消息发布后，（东莞市）政府才开始对我们有要求”上述工作人员表示。
"It started normal production today, and it was only after the news from the Shanghai Drug Administration yesterday that the government began to demand of us," the official said.
━━━━━“双黄连”相关药品批号85个,其中13个产品为口服液新京报记者在国家药监局官网上检索看到，与“双黄连”相关批号有85个产品，其中13个产品为双黄连口服液，其余的还有双黄连片、双黄连栓、双黄连胶囊、双黄连颗粒，双黄连糖浆、双黄连滴丸、双黄连含片、双黄连注射液、双黄连泡腾片等产品。
-- -- "Shuanghuanglian" 85 related pharmaceutical batches, 13 of which are oral liquid Xinhua News reporter found on the website of the State Administration of Pharmacy, 85 products, including Shuanghuanglian oral liquid, 13 products are Shuanghuanglian capsule, Shuanghuanglian granules, Shuanghuanglian syrup, Shuanghuanglian pills, Shuanghuanglian tablet, Shuanghuanglian Injection, Shuanghuanglian tablet and other products.
新京报记者在国家药监局国产药品中检索发现，目前国内有双黄连口服液生产批准的企业共有12家企业共13个生产批号，分别为黑龙江瑞格制药有限公司、河南太龙药业股份有限公司（国药准字Z41020565及国药准字Z20133010)、黑龙江省林宝药业有限责任公司、东莞市亚洲制药有限公司、哈药集团三精制药有限公司、南阳市新生制药有限公司、黑龙江金九药业股份有限公司、河南福森药业有限公司、河南天地药业股份有限公司、哈尔滨中药四厂有限公司、黑龙江珍宝岛药业股份有限公司、黑龙江喜人药业集团有限公司。
At present, 12 enterprises in China have approved the production of Shuanghuanglian oral liquid. They are Heilongjiang Rigg Pharmaceutical Co. Ltd., Henan Tai Long Pharmaceutical Co. Ltd. (Z41020565 and Z20133010), Heilongjiang Xinbao Pharmaceutical Co. Ltd., Henan Foshan Pharmaceutical Co. Ltd., Heilongjiang Pharmaceutical Co. Ltd.
上述公司中，河南太龙药业股份有限公司、黑龙江珍宝岛药业股份有限公司均为A股上市公司，哈药集团三精制药有限公司为上市公司哈药股份的全资子公司，河南天地药业为上市公司天士力控股子公司；河南福森药业有限公司为港股上市公司。
Among these companies, Henan Tai Long Pharmaceutical Co. Ltd. and Heilongjiang Pearl Island Pharmaceutical Co. Ltd. are A-shares listed companies, Haji Group Sanjing Pharmaceutical Co. Ltd. is a wholly-owned subsidiary of listed companies, Henan Tianshi Pharmaceutical Company is a subsidiary of listed companies; Henan Fuxin Pharmaceutical Co. Ltd. is a Hong Kong-listed company.
在太龙药业的介绍中，双黄连口服液的主治功能为“疏风解表，清热解毒。
In the introduction of Tai Long Pharmaceutical Industry, Shuang Huanglian oral liquid's main function is "wind-repellent meter, antipyretic detoxification.
用于外感风热所致的感冒，症见发热、咳嗽、咽痛。
For cold caused by external wind heat, symptoms of fever, cough, sore throat.
”2018年度，太龙药业生产的双黄连口服液为7622万支，双黄连口服液（浓缩型）为4252.24万支，双黄连口服液（儿童型）为5186万支。
In 2018, Tai Long produced 76.22 million Shuanghuanglian oral liquid (concentrated) 42,522,400, Shuanghuanglian oral liquid (children) 51.86 million.
根据哈药股份2018年年报，在2018年哈药股份生产的双黄连口服液为19146万支。
According to the 2018 annual report of pharmaceutical shares, in 2018, the production of Shuanghuanglian oral liquid of 19.146 million.
▲哈药股份2018年年报截图在哈药集团官网还显示，1月23日，哈药集团与九州通合作通过黑龙江省十字会向湖北省红十字会捐赠价值1000万元的药品，其中包括三精牌双黄连口服液、世一堂牌复方金银花颗粒等。
The 2018 annual report shows that on January 23, through the cross association of Heilongjiang Province, the company donated 10 million yuan worth of medicine to the Hubei Red Cross, including Sanjing Shuanghuanglian Oral Liquid and One World Class Compound Honeysuckle Granule.
另一家河南福森药业有限公司1月31日午间在官网发布消息称，公司春节假期紧急调配员工，调动企业内部一切资源，积极组织生产，所有生产线满负荷工作，加班加点保障产品质量和生产供应，尽可能满足市场需求。
Another company, Henan Fuxin Pharmaceutical Co., Ltd., announced on the official website at noon on January 31, the company spring holiday emergency deployment of staff, mobilize all the resources within the enterprise, actively organize production, all production lines to work at full capacity, overtime to ensure product quality and production supply, to meet market demand.
同时，优先把货物保障供应到疫情地区。
At the same time, priority is given to securing supplies to epidemic areas.
新京报记者 李云琦编辑 赵泽校对 何燕━━━━━“双黄连抗新型肺炎”未经人体试验，专家：慎用双黄连口服液等中药真的可预防新冠病毒感染吗？对此，北京世纪坛医院副主任药师金锐表示，双黄连口服液由金银花、黄芩、连翘三味中药组成，这三味中药具有良好的清热解毒、表里双清的作用。
2007-9-19 19: 19 [hide] "Shuanghuang Lianlian Anti-New Pneumonia" Without human testing, experts: With Shuanghuanglian oral liquid and other traditional Chinese medicines can really prevent the new crown virus infection, said Jin Rui, deputy director of Beijing Shiantan Hospital.
现代医学研究认为，双黄连口服液具有广谱抗病毒、抑菌、提高机体免疫功能的作用，是目前有效的广谱抗病毒药物之一。
Modern medical research shows that Shuanghuanglian oral liquid has broad-spectrum anti-virus, bacteriostatic and immune function enhancement function, is one of the effective broad-spectrum antiviral drugs.
“双黄连口服液可抑制新型冠状病毒”是通过现代医学病毒抑制角度进行的体外研究，并非按照传统中医辨证理论得出的临床应用结论。
"Shuanghuanglian Oral Liquid can inhibit the new coronavirus" is an in vitro study conducted from the perspective of modern medical virus suppression, rather than a clinical application conclusion based on the traditional TCM syndrome differentiation theory.
“单从双黄连口服液本身来讲，它可以认为是清热解毒的苦寒药，曾有中医院士到武汉参与治疗后提出，应慎用苦寒药。
"From the point of view of Shuanghuanglian oral liquid itself, it can be considered as a bitter cold medicine for antipyretic and detoxification.
”金瑞指出，双黄连口服液作为中成药，应在中医理论指导下进行研究，不建议正常人通过服用双黄连口服液来预防新冠病毒。
"As a Chinese patent medicine, Shuang Huanglian oral liquid should be studied under the guidance of traditional Chinese medicine theory," Jinrui said.
一位不愿透露姓名的三甲医院药师称，双黄连口服液本身具有广谱抗病毒作用，但对抑制新冠病毒是否有效研究尚少，且无人体试验，很多药物体外有效但进入人体后未必有效。
Shuanghuanglian oral liquid itself has a broad spectrum of anti-viral effect, but little research has been done on whether it is effective in inhibiting the new crown virus, and many drugs are effective in vitro but may not be effective in humans, said a pharmacist at Sanja Hospital, who declined to be named.
金锐表示，在此前国家卫健委发布的第四版新冠病毒诊疗方案的中医治疗方案中，推荐的金花清感颗粒就包含双黄连的组方，连花清瘟颗粒成分中也含有金银花和连翘。
Jin Rui said that prior to the release of the fourth edition of the Chinese medicine treatment program of the new crown virus treatment program, the recommended Jinhua Qingxiu granule contains Shuanghuanglian group, even the composition of Huaqing Rinderpest granules also contains honeysuckle and forsythia.
“实际上，如果在医学观察阶段出现乏力伴随发热，使用上述中成药即可，相当于双黄连的加强版。
"In fact, if fatigue is accompanied by fever during medical observation, the use of the Chinese patent medicine can be equivalent to Shuanghuanglian's enhanced version.
”金锐提醒，苦寒药容易导致腹泻、腹痛等副作用，脾胃虚寒的人、老人、小孩或近阶段食欲不佳，有腹泻症状的人群都不建议盲目服用。
Those with weak spleen and stomach, elderly people, children or people with near-term appetite may not be recommended for people with diarrhea.
Play▲兽用双黄连被疯抢 店家：有的顾客不听劝 认为兽用人用没区别。
Plays Animal Husband was raided: Some customers do not listen to the orcs advised to use no different.
新京报我们视频出品（ID：wevideo）新京报记者 张兆慧编辑 岳清秀 校对 卢茜相关阅读：双黄连能“抑毒”？医学人士：抢到也不能盲目吃又抢双黄连？我想起了当年的“板蓝根”双黄连，无货点击下图进入"全国新型冠状病毒感染肺炎实时地图"值班编辑 花木南中疾控独家回应：“人传人”早有推论，保守下结论有原因钟南山：不会因春运返程出现大传染北京小汤山医院正在复建，必要时启用补充本文未经新京报书面授权不得转载使用欢迎朋友圈分享。
Peking News, our video production (ID: wevedeo) journalist Yue Zhaohui, editor Yue Qingxiu, proofread by Lu Xian, medical personage: Can't eat and rob Huanglian Hospital in Beijing: I recall that the new coronavirus infection pneumonia in Beijing is being rebuilt.
发送到看一看 。
Send it to see.
一夜疯狂的双黄连：有中药企业大年初二就开始加班生产。
Crazy night Shuanghuanglian: Chinese medicine enterprises began to work overtime on the second day of the year.
长按识别前往小程序。
Long press identify to go to the applet.
var nickname = "新京报";。
var nickname = & quot; & quot; & quot; & quot; with Beijing News;
var msg_title = "一夜疯狂的双黄连：有中药企业大年初二就开始加班生产";。
Var msg _ title = & quot; & # 160; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45;
var msg_desc = "【新京报原创】“十来箱（双黄连口服液）半个小时就没了！”";。
Var msg _ desc = & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
title: '双黄连能“抑毒”？医学人士：抢到也不能盲目吃',。
& nbsp; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45;
subject_name: '新京报',。
subject _ name: & apos; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
title: '双黄连能“抑毒”？医学人士：抢到也不能盲目吃',。
& nbsp; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45; & # 45;
subject_name: '新京报',。
subject _ name: & apos; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
title: '又抢双黄连？我想起了当年的“板蓝根”',。
Running for Rhetoric again? I recall Randall & amp; quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp;.
subject_name: '新京报',。
subject _ name: & apos; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
title: '双黄连，无货',。
& quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & apos; & quot;.
subject_name: '新京报',。
subject _ name: & apos; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
title: '中疾控独家回应：没有隐瞒数据',。
& nbsp; CDC's exclusive response: Not having concealed data or information.
subject_name: '新京报',。
subject _ name: & apos; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
title: '中疾控独家回应：没有隐瞒数据',。
& nbsp; CDC's exclusive response: Not having concealed data or information.
subject_name: '新京报',。
subject _ name: & apos; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
title: '中疾控独家回应：没有隐瞒数据',。
& nbsp; CDC's exclusive response: Not having concealed data or information.
subject_name: '新京报',。
subject _ name: & apos; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
title: '钟南山：不会因春运返程出现大传染',。
Zhong Nan Shan: Not at least with AT & amp; apos; s service.
subject_name: '新京报',。
subject _ name: & apos; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
title: '钟南山：不会因春运返程出现大传染',。
Zhong Nan Shan: Not at least with AT & amp; apos; s service.
subject_name: '新京报',。
subject _ name: & apos; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
title: '钟南山：不会因春运返程出现大传染',。
Zhong Nan Shan: Not at least with AT & amp; apos; s service.
subject_name: '新京报',。
subject _ name: & apos; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
title: '“武汉8人‘传谣’”事件，专家：8人是可敬的',。
& quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
subject_name: '新京报',。
subject _ name: & apos; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
title: '北京小汤山医院正在复建，必要时启用补充',。
Beijing's Xiaotangshan Hospital is being rehabilitated and, if necessary, replenished with & apos;.
subject_name: '新京报',。
subject _ name: & apos; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
title: '北京小汤山医院正在复建，必要时启用补充',。
Beijing's Xiaotangshan Hospital is being rehabilitated and, if necessary, replenished with & apos;.
subject_name: '新京报',。
subject _ name: & apos; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot; & quot;
var title ="新京报";。
var title = & quot; New Beijing News & quot;;
